Search

Search Constraints

You searched for: Author/Creator Romaguera, Jorge

Search Results

11. Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. Issue 1 (January 2016)

12. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐Hodgkin lymphomas. (27th June 2013)

13. Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. (2nd September 2018)

15. Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B‐cell non‐Hodgkin lymphoma. (8th July 2014)

16. Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T‐cell lymphoma. (17th April 2013)

17. Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. (27th July 2015)

18. Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma. Issue 4 (3rd April 2018)

20. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. (6th January 2014)